Cilostazol: an antiplatelet agent for the neurointerventionist?

Author(s):
Bhogal, P.; Brouwer, P.A.; Makalanda, H.L.D.
Published
2016
Publication type
Article / Letter to editor

Abstract

Antiplatelet agents are essential for the successful

management of patients undergoing a variety of

neurointerventional procedures. The most commonly used

anti-platelet agents are aspirin, clopidogrel and prasugrel. However, there exist an alternative class of anti-platelet agent that may prove useful for neurointerventionists. In particular a drug called cilostazol may have numerous added advantages above and beyond its antiplatelet effect that may be valuable for our patients. In this short review we aim to highlight some of these potential advantages.

Date issued
2016-02-28
Language
English
Is part of
Journal of NeuroInterventional Surgery (2016), Vol. 8, no. 2, p. 208-209
hdl
1887/4304194
doi
10.1136/neurintsurg-2014-011570